Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM3 | P20309 | 2/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | WDR5 | P61964 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.40 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | GPR6 | P46095 | 3/20 | 0.39 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL303819 | 0.87 | CHRM3 (0.48) | CHRM3LMNAALDH1A1IRAK4KDM4E | |
| SCHEMBL1085490 | 0.86 | ALDH1A1 (0.50) | LMNAALDH1A1IRAK4KDM4EMAPT | |
| SCHEMBL302468 | 0.85 | JAK2 (0.48) | CHRM3LMNAALDH1A1KDM4EMAPT | |
| SCHEMBL4161715 | 0.85 | CHRM3 (0.50) | CHRM3THRBWDR5LMNAALDH1A1 | |
| SCHEMBL5141001 | 0.84 | CHRM3 (0.50) | CHRM3 | |
| SCHEMBL31427504 | 0.83 | ATM (0.43) | CHRM3LMNAALDH1A1IRAK4KDM4E | |
| SCHEMBL3542247 | 0.83 | ALDH1A1 (0.52) | CHRM3THRBALDH1A1RXFP1TP53 | |
| SCHEMBL4793286 | 0.83 | CHRM3 (0.48) | CHRM3THRBLMNAALDH1A1IRAK4 | |
| SCHEMBL302582 | 0.83 | CHRM3 (0.47) | CHRM3LMNAALDH1A1IRAK4KDM4E | |
| SCHEMBL167627 | 0.82 | CHRM3 (0.47) | CHRM3LMNAALDH1A1IRAK4KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090233795-A1 | Fungicidal Mixtres Based On 3-Monosubstituted N-Bipenyl-Pyrazolecarboxamides | BASF AKITENGESELLSCHAFT (DE) | 2009-09-17 | — | — | US | claimed |
| US-20090233795-A1 | Fungicidal Mixtres Based On 3-Monosubstituted N-Bipenyl-Pyrazolecarboxamides | BASF AKITENGESELLSCHAFT (DE) | 2009-09-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090233795-A1 | Fungicidal Mixtres Based On 3-Monosubstituted N-Bipenyl-Pyrazolecarboxamides | CBR3, CBR1, CYCS | CHRM3 370/4885THRB 4481/4885PKM 4383/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.